McKesson logo

McKesson

Stock
Stock
Ticker: MCK
MCK

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

McKesson has so far distributed $1.64 in 2026. The next dividend will be paid on 01.07.2026


$1.081

CHART BY

Frequently asked questions

What is McKesson's market capitalization?

The market capitalization of McKesson is $92.09B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is McKesson's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for McKesson is 19.96. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for McKesson?

McKesson's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $38.47. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for McKesson's stock?

Currently, 21 analysts cover McKesson's stock, with a consensus target price of $948.27. Analyst ratings provide insights into the stock's expected performance.

What is McKesson's revenue over the trailing twelve months?

Over the trailing twelve months, McKesson reported a revenue of $403.43B.

Is McKesson paying dividends?

Yes, McKesson is paying dividends. The next payment is scheduled for 01.07.2026, with an expected amount of .

What is the EBITDA for McKesson?

McKesson's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $7.10B. EBITDA measures the company's overall financial performance.

What is the free cash flow of McKesson?

McKesson has a free cash flow of $5.72B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does McKesson have, and what sector and industry does it belong to?

McKesson employs approximately 43,000 people. It operates in the Health Care sector, specifically within the Medical Distributors industry.

What is the free float of McKesson's shares?

The free float of McKesson is 120.16M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$92.09B
EPS (TTM) 
$38.47
Free Float 
120.16M
P/E ratio (TTM) 
19.96
Revenue (TTM) 
$403.43B
EBITDA (TTM) 
$7.10B
Free Cashflow (TTM) 
$5.72B

Pricing

1D span
$759.11$775.98
52W span
$639.29$999.00

Analyst Ratings

The price target is $948.27 and the stock is covered by 21 analysts.

Buy

18

Hold

2

Sell

1

Information

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Employees
43,000
Industries
Medical Distributors
Sector
Health Care

Identifier

Primary Ticker
MCK

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation